Wouters, Olivier J., Naci, Huseyin and Samani, Nilesh J (2015) QALYs in cost-effectiveness analysis: an overview for cardiologists. Heart, 10 (23). pp. 1868-1873. ISSN 1355-6037
|
PDF
- Accepted Version
Download (474Kb) | Preview |
Abstract
In recent years, cost-effectiveness data have strongly influenced clinical practice guidelines for several cardiovascular treatments. Economic considerations are increasingly common as health systems are under mounting pressure to maximise value for money. The quality-adjusted life year (QALY)—an outcome measure that expresses the duration and quality of life—is the main pillar of cost-effectiveness analyses. It is widely used in assessments of the clinical and economic value of new cardiovascular treatments, but how the QALY is derived is often unclear to clinicians. In this article, we first explain how QALYs are defined and calculated. We then review a selected set of cost-effectiveness analyses of recently introduced cardiovascular treatments and outline how these studies derived their QALYs. Finally, we discuss the limitations of the QALY and how the presentation of the measure could be improved in cost-effectiveness studies.
| Item Type: | Article |
|---|---|
| Official URL: | http://heart.bmj.com/ |
| Additional Information: | © 2015 BMJ Publishing Group Ltd and the British Cardiovascular Society |
| Library of Congress subject classification: | H Social Sciences > HD Industries. Land use. Labor R Medicine > RZ Other systems of medicine |
| Sets: | Research centres and groups > LSE Health and Social Care Research centres and groups > LSE Health Research centres and groups > LSE Enterprise |
| Date Deposited: | 29 Sep 2015 13:04 |
| URL: | http://eprints.lse.ac.uk/63798/ |
Actions (login required)
 |
Record administration - authorised staff only |
Download statistics
Download statistics